BioNxt Solutions Inc. (CVE:BNXT)

PRESS RELEASE

published on 08/20/2025 at 09:05, 7 months 4 days ago

BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline
BioNxt announces fast-tracked U.S. patent filing for BNT23001 sublingual thin-film cladribine formulation targeting neurological autoimmune disorders. Broad international patent core claims accepted for platform-level protection

Autoimmune Diseases Drug Delivery Neurological Disorders Patent Filing BioNxt
BRIEF

published on 08/09/2025 at 01:05, 7 months 15 days ago

BioNxt Solutions finalise son offre d'obligations convertibles sursouscrite

Placement Privé Développement De Produits Mandats Obligation Convertible Solutions BioNxt
BRIEF

published on 08/09/2025 at 01:05, 7 months 15 days ago

BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering

Private Placement Convertible Debenture Warrants Product Development BioNxt Solutions
PRESS RELEASE

published on 08/09/2025 at 01:00, 7 months 15 days ago

BioNxt Solutions Announces Closing of Final Tranche of Oversubscribed Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising $241,200 for convertible debentures and issuing Warrants. Funds intended for product development and IP filings

Private Placement Warrants Convertible Debentures BioNxt Solutions Inc. Product Development
BRIEF

published on 08/05/2025 at 09:10, 7 months 19 days ago

BioNxt Solutions renforce la protection des brevets pour le traitement de la sclérose en plaques

Sclérose En Plaques Technologie D'administration De Médicaments Solutions BioNxt Cladribine Sublinguale Protection Par Brevet
BRIEF

published on 08/05/2025 at 09:10, 7 months 19 days ago

BioNxt Solutions Advances Patent Protection for MS Treatment

Multiple Sclerosis Drug Delivery Technology Patent Protection BioNxt Solutions Sublingual Cladribine
PRESS RELEASE

published on 08/05/2025 at 09:05, 7 months 19 days ago

BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment
BioNxt Solutions Inc. makes significant progress in global patent portfolio with EPO and EAPO confirming acceptance of core claims for sublingual Cladribine thin-film formulation. Focus on innovation in MS treatment

BioNxt Solutions Inc. Patent Portfolio Cladribine EPO EAPO
BRIEF

published on 07/26/2025 at 00:05, 7 months 29 days ago

BioNxt Solutions Closes First Tranche of Debenture Placement

Private Placement Warrants Convertible Debentures Product Development BioNxt Solutions
BRIEF

published on 07/26/2025 at 00:05, 7 months 29 days ago

BioNxt Solutions clôture la première tranche de son placement d'obligations

Obligations Convertibles Placement Privé Développement De Produits Mandats Solutions BioNxt
PRESS RELEASE

published on 07/26/2025 at 00:00, 7 months 29 days ago

BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes first tranche of non-brokered private placement, raising $1,009,200 for drug delivery tech and IP development. Securities subject to statutory hold until Nov 26, 2025

Private Placement Convertible Debentures BioNxt Solutions Inc. Intellectual Property Drug Delivery Technologies

Published on 03/24/2026 at 23:42, 11 minutes ago

Presentation to Gold Coast Gold Conference
Published on 03/24/2026 at 23:00, 53 minutes ago

Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Published on 03/24/2026 at 18:55, 4 hours 58 minutes ago

Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 10 hours 23 minutes ago

GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 10 hours 23 minutes ago

Innodata Announces Date of Annual Shareholder Meeting

View all ACCESSWIRE

Published on 03/24/2026 at 21:08, 2 hours 45 minutes ago

Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 4 hours 3 minutes ago

EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 4 hours 11 minutes ago

ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 4 hours 48 minutes ago

WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 5 hours 13 minutes ago

EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026

View all EQS

Published on 03/24/2026 at 18:21, 5 hours 32 minutes ago

Résultats annuels 2025
Published on 03/24/2026 at 18:21, 5 hours 32 minutes ago

2025 Annual results
Published on 03/24/2026 at 18:00, 5 hours 53 minutes ago

i2S : Résultats annuels 2025
Published on 03/24/2026 at 17:46, 6 hours 6 minutes ago

NRJ GROUP - Avis résultats annuels 2025
Published on 03/24/2026 at 17:46, 6 hours 6 minutes ago

NRJ GROUP - Press release annual results 2025

View all LES ECHOS COMFI WIRE

News